S1 Text, S1 and S2 Tables are incorrect. Please view the corrected S1 Text, S1 and S2 Tables here.
Supporting Information
(PDF)
Each percent change is given in absolute value when compared to results from a run solved with ode45 for a 90 day simulation of a nine month-old APP/PS1 transgenic mouse with mg ⋅ kg−1 bexarotene treatment.
(PDF)
Parameters are increased by 10%, and the approximate corresponding percent change of the system is given for 0 mg ⋅ kg−1 and 100 mg ⋅ kg−1 of bexarotene.
(PDF)
Reference
- 1.Rosenthal J, Belfort G, Isaacson D (2016) Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico. PLoS ONE 11(4): e0153150 doi: 10.1371/journal.pone.0153150 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
(PDF)
Each percent change is given in absolute value when compared to results from a run solved with ode45 for a 90 day simulation of a nine month-old APP/PS1 transgenic mouse with mg ⋅ kg−1 bexarotene treatment.
(PDF)
Parameters are increased by 10%, and the approximate corresponding percent change of the system is given for 0 mg ⋅ kg−1 and 100 mg ⋅ kg−1 of bexarotene.
(PDF)